Biosimilar medicine fact sheet – rituximab
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
- Riximyo® was listed on the PBS on 1 October 2019.
- Truxima® was listed on the PBS on 1 January 2020.
- Ruxience® was listed on the PBS on 1 June 2022.
These brands are listed under the Section 100 Highly Specialised Drugs Program and the Efficient Funding of Chemotherapy Program.
Part of a collection: